Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with locally-advanced unresectable non-small-cell lung cancer: a KSMO-ESMO initiative endorsed by CSCO, ISMPO, JSMO, MOS, SSO and TOS

The most recent version of the European Society for Medical Oncology (ESMO) Clinical Practice Guidelines for the diagnosis, treatment and follow-up of early and locally-advanced non-small-cell lung cancer (NSCLC) was published in 2017, and covered the diagnosis, staging, management and treatment of...

Full description

Saved in:
Bibliographic Details
Main Authors: Park, Keunchil, Vansteenkiste, J., Lee, K.H., Pentheroudakis, G., Zhou, C., Prabhash, K., Seto, T., Voon, P.J., Tan, D.S.W., Yang, J.C.H., Wang, J., Babu, K. Govind, Nakayama, Y., Alip, Adlinda, Chua, K.L.M., Cheng, J.C.-H., Senan, S., Ahn, Y.C., Kim, T.-Y., Ahn, H.K., Peters, S., Yoshino, T., Douillard, J.-Y.
Format: Article
Published: Elsevier 2020
Subjects:
Online Access:http://eprints.um.edu.my/25414/
https://doi.org/10.1016/j.annonc.2019.10.026
Tags: Add Tag
No Tags, Be the first to tag this record!
id my.um.eprints.25414
record_format eprints
spelling my.um.eprints.254142020-08-19T00:56:28Z http://eprints.um.edu.my/25414/ Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with locally-advanced unresectable non-small-cell lung cancer: a KSMO-ESMO initiative endorsed by CSCO, ISMPO, JSMO, MOS, SSO and TOS Park, Keunchil Vansteenkiste, J. Lee, K.H. Pentheroudakis, G. Zhou, C. Prabhash, K. Seto, T. Voon, P.J. Tan, D.S.W. Yang, J.C.H. Wang, J. Babu, K. Govind Nakayama, Y. Alip, Adlinda Chua, K.L.M. Cheng, J.C.-H. Senan, S. Ahn, Y.C. Kim, T.-Y. Ahn, H.K. Peters, S. Yoshino, T. Douillard, J.-Y. R Medicine The most recent version of the European Society for Medical Oncology (ESMO) Clinical Practice Guidelines for the diagnosis, treatment and follow-up of early and locally-advanced non-small-cell lung cancer (NSCLC) was published in 2017, and covered the diagnosis, staging, management and treatment of both early stage I and II disease and locally-advanced stage III disease. At the ESMO Asia Meeting in November 2018, it was decided by both the ESMO and the Korean Society of Medical Oncology (KSMO) to convene a special face-to-face guidelines meeting in 2019 in Seoul. The aim was to adapt the ESMO 2017 guidelines to take into account potential differences related to ethnicity, cancer biology and standard practices associated with the treatment of locally-advanced, unresectable NSCLC in Asian patients. These guidelines represent the consensus opinions reached by those experts in the treatment of patients with lung cancer who represented the oncology societies of Korea (KSMO), China (CSCO), India (ISMPO), Japan (JSMO), Malaysia (MOS), Singapore (SSO) and Taiwan (TOS). The voting was based on scientific evidence, and it was independent of both local current treatment practices and the treatment availability and reimbursement situations in the individual participating Asian countries. © 2019 European Society for Medical Oncology Elsevier 2020 Article PeerReviewed Park, Keunchil and Vansteenkiste, J. and Lee, K.H. and Pentheroudakis, G. and Zhou, C. and Prabhash, K. and Seto, T. and Voon, P.J. and Tan, D.S.W. and Yang, J.C.H. and Wang, J. and Babu, K. Govind and Nakayama, Y. and Alip, Adlinda and Chua, K.L.M. and Cheng, J.C.-H. and Senan, S. and Ahn, Y.C. and Kim, T.-Y. and Ahn, H.K. and Peters, S. and Yoshino, T. and Douillard, J.-Y. (2020) Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with locally-advanced unresectable non-small-cell lung cancer: a KSMO-ESMO initiative endorsed by CSCO, ISMPO, JSMO, MOS, SSO and TOS. Annals of Oncology, 31 (2). pp. 191-201. ISSN 0923-7534 https://doi.org/10.1016/j.annonc.2019.10.026 doi:10.1016/j.annonc.2019.10.026
institution Universiti Malaya
building UM Library
collection Institutional Repository
continent Asia
country Malaysia
content_provider Universiti Malaya
content_source UM Research Repository
url_provider http://eprints.um.edu.my/
topic R Medicine
spellingShingle R Medicine
Park, Keunchil
Vansteenkiste, J.
Lee, K.H.
Pentheroudakis, G.
Zhou, C.
Prabhash, K.
Seto, T.
Voon, P.J.
Tan, D.S.W.
Yang, J.C.H.
Wang, J.
Babu, K. Govind
Nakayama, Y.
Alip, Adlinda
Chua, K.L.M.
Cheng, J.C.-H.
Senan, S.
Ahn, Y.C.
Kim, T.-Y.
Ahn, H.K.
Peters, S.
Yoshino, T.
Douillard, J.-Y.
Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with locally-advanced unresectable non-small-cell lung cancer: a KSMO-ESMO initiative endorsed by CSCO, ISMPO, JSMO, MOS, SSO and TOS
description The most recent version of the European Society for Medical Oncology (ESMO) Clinical Practice Guidelines for the diagnosis, treatment and follow-up of early and locally-advanced non-small-cell lung cancer (NSCLC) was published in 2017, and covered the diagnosis, staging, management and treatment of both early stage I and II disease and locally-advanced stage III disease. At the ESMO Asia Meeting in November 2018, it was decided by both the ESMO and the Korean Society of Medical Oncology (KSMO) to convene a special face-to-face guidelines meeting in 2019 in Seoul. The aim was to adapt the ESMO 2017 guidelines to take into account potential differences related to ethnicity, cancer biology and standard practices associated with the treatment of locally-advanced, unresectable NSCLC in Asian patients. These guidelines represent the consensus opinions reached by those experts in the treatment of patients with lung cancer who represented the oncology societies of Korea (KSMO), China (CSCO), India (ISMPO), Japan (JSMO), Malaysia (MOS), Singapore (SSO) and Taiwan (TOS). The voting was based on scientific evidence, and it was independent of both local current treatment practices and the treatment availability and reimbursement situations in the individual participating Asian countries. © 2019 European Society for Medical Oncology
format Article
author Park, Keunchil
Vansteenkiste, J.
Lee, K.H.
Pentheroudakis, G.
Zhou, C.
Prabhash, K.
Seto, T.
Voon, P.J.
Tan, D.S.W.
Yang, J.C.H.
Wang, J.
Babu, K. Govind
Nakayama, Y.
Alip, Adlinda
Chua, K.L.M.
Cheng, J.C.-H.
Senan, S.
Ahn, Y.C.
Kim, T.-Y.
Ahn, H.K.
Peters, S.
Yoshino, T.
Douillard, J.-Y.
author_facet Park, Keunchil
Vansteenkiste, J.
Lee, K.H.
Pentheroudakis, G.
Zhou, C.
Prabhash, K.
Seto, T.
Voon, P.J.
Tan, D.S.W.
Yang, J.C.H.
Wang, J.
Babu, K. Govind
Nakayama, Y.
Alip, Adlinda
Chua, K.L.M.
Cheng, J.C.-H.
Senan, S.
Ahn, Y.C.
Kim, T.-Y.
Ahn, H.K.
Peters, S.
Yoshino, T.
Douillard, J.-Y.
author_sort Park, Keunchil
title Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with locally-advanced unresectable non-small-cell lung cancer: a KSMO-ESMO initiative endorsed by CSCO, ISMPO, JSMO, MOS, SSO and TOS
title_short Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with locally-advanced unresectable non-small-cell lung cancer: a KSMO-ESMO initiative endorsed by CSCO, ISMPO, JSMO, MOS, SSO and TOS
title_full Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with locally-advanced unresectable non-small-cell lung cancer: a KSMO-ESMO initiative endorsed by CSCO, ISMPO, JSMO, MOS, SSO and TOS
title_fullStr Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with locally-advanced unresectable non-small-cell lung cancer: a KSMO-ESMO initiative endorsed by CSCO, ISMPO, JSMO, MOS, SSO and TOS
title_full_unstemmed Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with locally-advanced unresectable non-small-cell lung cancer: a KSMO-ESMO initiative endorsed by CSCO, ISMPO, JSMO, MOS, SSO and TOS
title_sort pan-asian adapted esmo clinical practice guidelines for the management of patients with locally-advanced unresectable non-small-cell lung cancer: a ksmo-esmo initiative endorsed by csco, ismpo, jsmo, mos, sso and tos
publisher Elsevier
publishDate 2020
url http://eprints.um.edu.my/25414/
https://doi.org/10.1016/j.annonc.2019.10.026
_version_ 1680857030179422208
score 13.160551